◼ In a June 2009 email, President Obama’s point person on health care promised the pharmaceutical industry it would be protected against efforts to allow cheap drugs to be re-imported from Canada, because drug lobbyists had been “constructive” in their secret negotiations with White House officials. - Philip Klein/Washington Examiner
The email is just one of thousands that House Republicans mined through as part of a more than a year-long investigation into Obama’s closed-door deal making with PhRMA, the drug industry lobbying group.
Though it was previously known that Obama had cut a deal with drug companies, a memo released today by the House Energy and Commerce Committee provides more specific details than have been previously reported.
The disclosures provide further evidence that once in office, Obama tossed aside his promises to be transparent and stand up to special interest groups.
